Featured Research

from universities, journals, and other organizations

New Strain Of Drug-resistant Tuberculosis In South Africa Traced To Lack Of Drug Susceptibility Testing

Date:
November 27, 2007
Source:
Infectious Diseases Society of America
Summary:
In South Africa, the 2001 implementation of the World Health Organization's antituberculosis program may have inadvertently helped to create a new strain of extensively drug-resistant tuberculosis. Researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years.

In South Africa, the 2001 implementation of the World Health Organization’s anti-tuberculosis program may have inadvertently helped to create a new strain of extensively drug-resistant tuberculosis (XDR TB).

In a new study published in the December 1 issue of Clinical Infectious Diseases, currently available online, researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years. They found that at the time of the 2001 adoption of the DOT+ strategy for multi-drug resistant strains, the strain was already resistant to one or more of the drugs mandated by that strategy, thus allowing the strain to survive and develop resistance to additional drugs.

“The spread of a highly transmissible strain of drug-resistant tuberculosis has been facilitated by applying standard treatment regimens for susceptible and multi-drug resistant tuberculosis in the absence of drug resistance surveillance,” said one of the authors, A. Willem Sturm, MD, of the University of KwaZulu-Natal’s Nelson R. Mandela School of Medicine in South Africa. “Public health programs for the treatment and control of infectious diseases need to be supported by drug resistance surveillance programs.”

Like all bacteria, M. tuberculosis can evolve and develop resistance to the drugs that have historically killed them. The strategy that has been used to limit the development of drug-resistant TB is to treat the patient with multiple drugs so that if one drug is ineffective, then the others will ensure the elimination of the bacteria.

Drug-resistant M. tuberculosis develops when tuberculosis patients cannot or do not comply with the medication regimen. A second line of drugs has been used to treat those infected with drug-resistant TB. This second-line medication regimen was adopted in South Africa in 2001 to treat drug-resistant TB.

Unfortunately, at least one strain of M. tuberculosis in South Africa had already developed resistance to one or more of these second-line drugs by the time they were introduced. Drug susceptibility tests would have warned doctors that the standard second-line regimen was unlikely to help the patient but was likely to lead to additional drug-resistance, but these tests were not performed or were not available. Indeed, the reduced efficacy of the regimen allowed the strain to survive and, over time, develop resistances to other drugs.

The authors recorded the development of resistance to seven drugs in just over a decade in one strain of M. tuberculosis. There are very few treatment options for patients infected with XDR TB. For the most part, patients are given drugs that had been used to treat tuberculosis but which were abandoned when today’s first-line drugs became available. The older drugs were abandoned because they were less effective or more toxic.

The authors call for an increased use of drug resistance surveillance programs to help forestall the development of drug-resistance in M. tuberculosis.

Clarification:

It has come to the attention of IDSA and CID that some media coverage of the above article has suggested that the World Health Organization’s TB control program is responsible for the development of extensively drug-resistant tuberculosis (XDR TB) in South Africa. The article in question traces the development of XDR TB during the implementation of a tuberculosis control program. In their conclusion, the authors state, “It is postulated that the introduction of these programs in the absence of susceptibility testing or drug resistance surveillance has been instrumental in the development of XDR in this highly transmissible…strain.”

The World Health Organization (WHO) provides guidance to countries implementing TB control programs. Its guidance has recommended these programs include drug resistance testing if resources are available. As an advisory body, WHO does not implement TB control programs. The article in CID did not evaluate the performance of WHO, or other authorities, in the implementation of the TB control program.

It should be noted that manuscripts published in CID reflect the work of the author and not necessarily the views of the journal or IDSA.


Story Source:

The above story is based on materials provided by Infectious Diseases Society of America. Note: Materials may be edited for content and length.


Cite This Page:

Infectious Diseases Society of America. "New Strain Of Drug-resistant Tuberculosis In South Africa Traced To Lack Of Drug Susceptibility Testing." ScienceDaily. ScienceDaily, 27 November 2007. <www.sciencedaily.com/releases/2007/10/071022120253.htm>.
Infectious Diseases Society of America. (2007, November 27). New Strain Of Drug-resistant Tuberculosis In South Africa Traced To Lack Of Drug Susceptibility Testing. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2007/10/071022120253.htm
Infectious Diseases Society of America. "New Strain Of Drug-resistant Tuberculosis In South Africa Traced To Lack Of Drug Susceptibility Testing." ScienceDaily. www.sciencedaily.com/releases/2007/10/071022120253.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins